Location: VIA SAVI 10, 56126 PISA
Email: carlotta.antoniotti@unipi.it
Profile
Teaching
Teaching activity
Teaching responsibility for modules/courses
- Oncologia (modulo dell'insegnamento ricerca applicata alla biomedicina cod. 0031f) per Laurea Magistrale in Scienze infermieristiche e ostetriche
Incarichi di co-docenza in moduli/insegnamenti
- Tirocinio di Assistenza Ospedaliera e Igiene (Cod. 290FF) per Laurea Magistrale Ciclo Unico 6 anni in Medicina e chirurgia
Research
Publications
- Risk of disease progression in first-line metastatic colorectal cancer therapy to guide disease reassessments?analysis of 11 trials by AIO and GONO (Germani, M. M.; Heinemann, V.; Rossini, D.; Fischer Von Weikersthal, L.; Pietrantonio, F.; Heinrich, K.; Stahler, A.; Lonardi, S.; Kaiser, F.; Decker, T.; Salvatore, L.; Weiss, L.; Morano, F.; Fuchs, M.; Bergamo, F.; Antoniotti, C.; Masi, G.; Stintzing, S.; Frumento, P.; Cremolini, C.; Modest, D. P. - 2025 - 1.1 Articolo in rivista)
- FOLFOXIRI/bevacizumab versus doublets/bevacizumab as initial therapy of unresectable liver-only, right-sided and/or RAS or BRAF mutated metastatic colorectal cancer: An individual patient data-based pooled analysis of randomized trials (Antoniotti, Carlotta; Marmorino, Federica; Rossini, Daniele; Schmoll, Hans Joachim; Lonardi, Sara; Tonini, Giuseppe; Borelli, Beatrice; Cupini, Samanta; Stein, Alexander; Moretto, Roberto; Bergamo, Francesca; Ronzoni, Monica; Germani, Marco Maria; Zaniboni, Alberto; Fazio, Roberta; De Grandis, Maria Caterina; Ongaro, Elena; Masi, Gianluca; Cremolini, Chiara - 2025 - 1.1 Articolo in rivista)
- Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials (Germani, Marco Maria; Borelli, Beatrice; Hashimoto, Tadayoshi; Nakamura, Yoshiaki; Oldani, Simone; Battaglin, Francesca; Bergamo, Francesca; Salvatore, Lisa; Stahler, Arndt; Antoniotti, Carlotta; Shitara, Kohei; Venook, Alan; Oki, Eiji; Muro, Kei; Ugolini, Clara; Soeda, Junpei; Lonardi, Sara; Pietrantonio, Filippo; Lenz, Heinz-Josef; Modest, Dominik Paul; Yoshino, Takayuki; Cremolini, Chiara - 2025 - 1.1 Articolo in rivista)
- Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO (Ciracì, P; Germani, M M; Pietrantonio, F; Manca, P; Lonardi, S; Busico, A; Bergamo, F; Burgio, V; Mannavola, F; Di Donato, S; Fenocchio, E; Palermo, F; Capone, I; De Grandis, M C; Pella, N; Scartozzi, M; Antonuzzo, L; Passardi, A; Claravezza, M; Salvatore, L; Tamberi, S; Randon, G; Conca, E; Conca, V; Antoniotti, C; Moretto, R; Masi, G; Boni, L; Rossini, D; Cremolini, C - 2025 - 1.1 Articolo in rivista)
- A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer (Acha-Sagredo, Amelia; Andrei, Pietro; Clayton, Kalum; Taggart, Emma; Antoniotti, Carlotta; Woodman, Chloé A; Afrache, Hassnae; Fourny, Constance; Armero, Maria; Moinudeen, Hafsa Kaja; Green, Mary; Bhardwaj, Nisha; Mikolajczak, Anna; Rodriguez-Lopez, Maria; Crawford, Marg; Connick, Emma; Lim, Steven; Hobson, Philip; Linares, Josep; Ignatova, Ekaterina; Pelka, Diana; Smyth, Elizabeth C; Diamantis, Nikolaos; Sosnowska, Dominika; Carullo, Martina; Ciraci, Paolo; Bergamo, Francesca; Intini, Rossana; Nye, Emma; Barral, Patricia; Mishto, Michele; Arnold, James N; Lonardi, Sara; Cremolini, Chiara; Fontana, Elisa; Rodriguez-Justo, Manuel; Ciccarelli, Francesca D - 2025 - 1.1 Articolo in rivista)
- Prognostic impact of depth of response and early tumour shrinkage in patients with BRAF V600E -mutated metastatic colorectal cancer treated with targeted therapy (Vetere, Guglielmo; Germani, Marco Maria; Antoniotti, Carlotta; Salvatore, Lisa; Pietrantonio, Filippo; Lonardi, Sara; Bensi, Maria; Ghelardi, Filippo; Calegari, Maria Alessandra; Intini, Rossana; Minelli, Alessandro; Sullo, Francesco Giulio; Boccaccio, Chiara; Taravella, Ada; Puccini, Alberto; Lavacchi, Daniele; Noto, Laura; Salati, Massimiliano; Scartozzi, Mario; Cremolini, Chiara - 2025 - 1.1 Articolo in rivista)
- The relative dose intensity of first-line FOLFOXIRI and FOLFOX/FOLFIRI both in combination with bevacizumab affects prognosis of metastatic colorectal cancer patients: A pooled analysis of TRIBE and TRIBE2 studies (Moretto, R; Rossini, D; Polito, Mariam Grazia; Antoniotti, Carlotta; Intini, Rossana; Conca, Veronica; Andena, Paola; Carullo, Martina; Salvatore, Lisa; Germani, Marco Maria; Bergamo, Francesca; Passardi, Alessandro; Ciracì, Paolo; Tamburini, Emiliano; Boccaccio, Chiara; Zaniboni, Alberto; Masi, Gianluca; Pietrantonio, Filippo; Lonardi, Sara; Cremolini, C - 2025 - 1.1 Articolo in rivista)
- Exploring the Prognostic and Predictive Impact of Genomic Loss of Heterozygosity and Homologous Recombination Deficiency Alterations in Patients With Metastatic Colorectal Cancer (Moretto, Roberto; Germani, Marco Maria; Carullo, Martina; Conca, Veronica; Minelli, Alessandro; Giordano, Mirella; Bruno, Rossella; Rossini, Daniele; Gusmaroli, Eleonora; De Grandis, Maria Caterina; Antoniotti, Carlotta; Salvatore, Lisa; Passardi, Alessandro; Tamberi, Stefano; Scartozzi, Mario; Pietrantonio, Filippo; Lonardi, Sara; Ugolini, Clara; Masi, Gianluca; Cremolini, Chiara - 2025 - 1.1 Articolo in rivista)
- Liver metastases do not predict resistance to the addition of atezolizumab to first-line FOLFOXIRI plus bevacizumab in proficient MMR metastatic colorectal cancer: a secondary analysis of the AtezoTRIBE study (Antoniotti, C; Carullo, M; Rossini, D; Pietrantonio, F; Salvatore, L; Lonardi, S; Tamberi, S; Sciortino, C; Conca, V; Calegari, M A; Ciracì, P; Tamburini, E; Bergamo, F; Boccaccio, C; Passardi, A; Ritorto, G; Ugolini, C; Aprile, G; Galon, J; Cremolini, C - 2025 - 1.1 Articolo in rivista)
- Late-line options for patients with metastatic colorectal cancer: a review and evidence-based algorithm (Ciracì, Paolo; Studiale, Vittorio; Taravella, Ada; Antoniotti, Carlotta; Cremolini, Chiara - 2024 - 1.1 Articolo in rivista)